NIH Funding · FY2024
Total Funding
$1.1M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#12,852
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.1M across 2 grants · National rank #12852.
Top grants by award amount
Aaron D Schuler's NIH grant portfolio, ranked by award amount.
- 5R44CA278187-02R44A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)$745.1Kaward amount
- 1R44CA291622-01A1R44A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients$400Kaward amount
Affiliation
Institutions that have administered grants for Aaron D Schuler.
Affiliated with Syntrix Biosystems, Inc. (WA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardSyntrix Biosystems, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
Related investigators
Other NIH-funded PIs frequently associated with Aaron D Schuler.
Explore further
Find collaborators for Aaron D Schuler
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Syntrix Biosystems, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →